Ignite Creation Date:
2024-07-17 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497543
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-05
Brief Title:
Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic
Sponsor:
Hunan Province Tumor Hospital
Organization:
Hunan Province Tumor Hospital
Organization Data
Organization:
Hunan Province Tumor Hospital
Class:
OTHER
Study ID:
20240705
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hunan Province Tumor Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Yongchang Zhang
Responsible Party Title:
Head of Medical Oncology Director of Early Clinical Trial Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hunan Province Tumor Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Second Peoples Hospital of Hunan | OTHER |